PDF) Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease
IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Therapeutic Strategies for Gaucher Disease: Miglustat (NB-DNJ) as a Pharmacological Chaperone for Glucocerebrosidase and the Different Thermostability of Velaglucerase Alfa and Imiglucerase | Molecular Pharmaceutics
Full article: Imiglucerase and its use for the treatment of Gaucher's disease
Full article: Imiglucerase in the treatment of Gaucher disease: a history and perspective
IJMS | Free Full-Text | Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance
PDF) Endocrine and metabolic disorders in patients with Gaucher disease type 1: A review
PDF) Clinical manifestations and management of Gaucher disease
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis | PLOS Biology
Frontiers | Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases
Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease - eBioMedicine
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
JCM | Free Full-Text | Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
Cells | Free Full-Text | Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature
Cells | Free Full-Text | Highlights on Genomics Applications for Lysosomal Storage Diseases
Gaucher disease: haematological presentations and complications - Thomas - 2014 - British Journal of Haematology - Wiley Online Library
Biomolecules | Free Full-Text | Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease
IJMS | Free Full-Text | Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity
Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses - ScienceDirect
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease | Scientific Reports
JCM | Free Full-Text | Glucocerebrosidase: Functions in and Beyond the Lysosome
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
PDF) Gaucher disease | Hadil Mohamed - Academia.edu
Intestinal insulin/IGF1 signalling through FoxO1 regulates epithelial integrity and susceptibility to colon cancer | Nature Metabolism
Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gauch
Nutrients | Free Full-Text | Plasma Metabolites Related to Peripheral and Hepatic Insulin Sensitivity Are Not Directly Linked to Gut Microbiota Composition
